These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 34948035)

  • 21. Cannabinoid signalling in the immature brain: Encephalopathies and neurodevelopmental disorders.
    Sagredo O; Palazuelos J; Gutierrez-Rodriguez A; Satta V; Galve-Roperh I; Martínez-Orgado J
    Biochem Pharmacol; 2018 Nov; 157():85-96. PubMed ID: 30118663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine.
    Nagy-Grócz G; Zádor F; Dvorácskó S; Bohár Z; Benyhe S; Tömböly C; Párdutz Á; Vécsei L
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.
    Estrada JA; Contreras I
    Curr Neuropharmacol; 2020; 18(8):769-787. PubMed ID: 32065105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glial adenosine kinase--a neuropathological marker of the epileptic brain.
    Aronica E; Sandau US; Iyer A; Boison D
    Neurochem Int; 2013 Dec; 63(7):688-95. PubMed ID: 23385089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus.
    Ludányi A; Eross L; Czirják S; Vajda J; Halász P; Watanabe M; Palkovits M; Maglóczky Z; Freund TF; Katona I
    J Neurosci; 2008 Mar; 28(12):2976-90. PubMed ID: 18354002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
    Romigi A; Bari M; Placidi F; Marciani MG; Malaponti M; Torelli F; Izzi F; Prosperetti C; Zannino S; Corte F; Chiaramonte C; Maccarrone M
    Epilepsia; 2010 May; 51(5):768-72. PubMed ID: 19817812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3.
    Rodríguez-Cueto C; Hernández-Gálvez M; Hillard CJ; Maciel P; García-García L; Valdeolivas S; Pozo MA; Ramos JA; Gómez-Ruiz M; Fernández-Ruiz J
    Neuroscience; 2016 Dec; 339():191-209. PubMed ID: 27717809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of control of neuron survival by the endocannabinoid system.
    Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
    Curr Pharm Des; 2008; 14(23):2279-88. PubMed ID: 18781978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aquaporin-4 and epilepsy.
    Binder DK; Nagelhus EA; Ottersen OP
    Glia; 2012 Aug; 60(8):1203-14. PubMed ID: 22378467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation.
    López-Gallardo M; Llorente R; Llorente-Berzal A; Marco EM; Prada C; Di Marzo V; Viveros MP
    Dev Neurobiol; 2008 Oct; 68(12):1429-40. PubMed ID: 18726913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The endocannabinoid system role in the pathogenesis of obesity and depression].
    Zdanowicz A; Kaźmierczak W; Wierzbiński P
    Pol Merkur Lekarski; 2015 Jul; 39(229):61-6. PubMed ID: 26277182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.
    Lazarowski A; Ramos AJ; García-Rivello H; Brusco A; Girardi E
    Cell Mol Neurobiol; 2004 Feb; 24(1):77-85. PubMed ID: 15049512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory response in epilepsy is mediated by glial cell gap junction pathway (Review).
    Wang G; Wang J; Xin C; Xiao J; Liang J; Wu X
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuron-glia relationships in human and experimental epilepsy: a biochemical point of view.
    Grisar TM
    Adv Neurol; 1986; 44():1045-73. PubMed ID: 2871719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of glial membrane ion channels in seizures and epileptogenesis.
    D'Ambrosio R
    Pharmacol Ther; 2004 Aug; 103(2):95-108. PubMed ID: 15369678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.
    Deshpande LS; Sombati S; Blair RE; Carter DS; Martin BR; DeLorenzo RJ
    Neurosci Lett; 2007 Jan; 411(1):11-6. PubMed ID: 17110038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CB
    Ji X; Zeng Y; Wu J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy.
    Smolyakova AM; Zagzoog A; Brandt AL; Black T; Mohamed K; Laprairie RB
    J Clin Neurophysiol; 2020 Jan; 37(1):15-27. PubMed ID: 31895186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epileptogenesis mediated by glial cells].
    Koizumi S; Sano F
    Nihon Yakurigaku Zasshi; 2018; 152(6):268-274. PubMed ID: 30531096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions.
    Behl T; Kaur G; Bungau S; Jhanji R; Kumar A; Mehta V; Zengin G; Brata R; Hassan SSU; Fratila O
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.